CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases
Download the current issue as a PDF (1.40 MB - 31 pages)
Published by: The Public Health Agency of Canada
Date published: April 7, 2016
Submit a manuscript
Table of contents
Invasive bacterial diseases in Northern Canada, 2006–2013
Li YA, Martin I, Tsang R, Squires SG, Demczuk W, Desai S
Evaluation of the enhanced Invasive Pneumococcal Disease Surveillance System (eIPDSS) pilot project
Wijayasri S, Li YA, Squires SG, Martin I, Demczuk W, Mukhi S
Outbreak of Shigella sonnei in Montréal's ultra-Orthodox Jewish community, 2015
Pilon PA, Camara B, Bekal S
Interim recommendations for the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia
German GJ, Jamieson FB, Gilmour M, Almohri H, Bullard J, Domingo MC, Fuller J, Girouard G, Haldane D, Hoang L, Levett PN, Longtin J, Melano R, Needle R, Patel SN, Rebbapragada A, Reyes RC, Mulvey MR
Efficacy and safety of RTS,S/AS01 malaria vaccine
The RTS,S/AS01 vaccine continues to show modest protection
Evaluation of anthrax vaccine safety in 18-20 year olds
Single dose tetravalent dengue vaccine
April 18–20, 2016. 19th Annual Conference on Vaccine Research. Baltimore, MD, USA.
June 13–16, 2016. Public Health 2016. Canadian Public Health Association. Toronto, ON.
July 18–22, 2016. 21st International AIDS Conference (AIDS 2016). Durban, South Africa.
Report a problem or mistake on this page
- Date modified: